TipRanks
Advertisement
Advertisement
Ionis Pharmaceuticals upgraded to Outperform from Market Perform at BMO Capital
PremiumThe FlyIonis Pharmaceuticals upgraded to Outperform from Market Perform at BMO Capital
20h ago
3 Healthcare Stocks with Strong Buy Ratings and Double-Digit Upside
Premium
Market News
3 Healthcare Stocks with Strong Buy Ratings and Double-Digit Upside
1d ago
Ionis Pharmaceuticals recent selloff overdone, says Citi
Premium
The Fly
Ionis Pharmaceuticals recent selloff overdone, says Citi
1d ago
Ionis Pharmaceuticals upgraded to Buy from Neutral at UBS
PremiumThe FlyIonis Pharmaceuticals upgraded to Buy from Neutral at UBS
8d ago
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
Premium
Market News
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
15d ago
Ionis Advances CHAMPION Phase 3 Trial in Angelman Syndrome, Raising Long‑Term Optionality for IONS Investors
Premium
Company Announcements
Ionis Advances CHAMPION Phase 3 Trial in Angelman Syndrome, Raising Long‑Term Optionality for IONS Investors
24d ago
Ionis announces Phase 3 FUSION study of ulefnersen met primary endpoint
PremiumThe FlyIonis announces Phase 3 FUSION study of ulefnersen met primary endpoint
1M ago
Ionis Pharmaceuticals price target lowered to $70 from $76 at JPMorgan
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $70 from $76 at JPMorgan
1M ago
Cathie Wood’s ARK Investment buys 100K shares of Ionis Pharmaceuticals today
Premium
The Fly
Cathie Wood’s ARK Investment buys 100K shares of Ionis Pharmaceuticals today
1M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―